NO20074419L - Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom - Google Patents

Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom

Info

Publication number
NO20074419L
NO20074419L NO20074419A NO20074419A NO20074419L NO 20074419 L NO20074419 L NO 20074419L NO 20074419 A NO20074419 A NO 20074419A NO 20074419 A NO20074419 A NO 20074419A NO 20074419 L NO20074419 L NO 20074419L
Authority
NO
Norway
Prior art keywords
drugs
receptor antagonists
manufacture
endothelin receptor
fight disease
Prior art date
Application number
NO20074419A
Other languages
English (en)
Inventor
Klaus Muenter
Michael Kirchengast
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20074419L publication Critical patent/NO20074419L/no
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Anvendelse av endotelinreseptor-antagonister for å produsere medikamenter for å kontrollere fedme og sykdommer forårsaket av fedme. ?? ?? ?? ?? 1
NO20074419A 1997-12-05 2007-08-30 Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom NO20074419L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19754082A DE19754082A1 (de) 1997-12-05 1997-12-05 Methode zur Bekämpfung der Fettleibigkeit
PCT/EP1998/007501 WO1999029308A2 (de) 1997-12-05 1998-11-21 Methode zur bekämpfung der fettleibigkeit

Publications (1)

Publication Number Publication Date
NO20074419L true NO20074419L (no) 2000-06-02

Family

ID=7850913

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20002777A NO324694B1 (no) 1997-12-05 2000-05-30 Anvendelse av endotelinreseptor-antagonister for fremstilling av medikamenter for a kontrollere hyperlipidemi.
NO20074419A NO20074419L (no) 1997-12-05 2007-08-30 Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20002777A NO324694B1 (no) 1997-12-05 2000-05-30 Anvendelse av endotelinreseptor-antagonister for fremstilling av medikamenter for a kontrollere hyperlipidemi.

Country Status (17)

Country Link
US (1) US6197780B1 (no)
EP (1) EP1035851B1 (no)
JP (1) JP2002512173A (no)
KR (1) KR20010032779A (no)
CN (1) CN1152685C (no)
AT (1) ATE204172T1 (no)
AU (1) AU751053B2 (no)
BR (1) BR9815335A (no)
CA (1) CA2311423C (no)
CZ (1) CZ300442B6 (no)
DE (2) DE19754082A1 (no)
ES (1) ES2162493T3 (no)
HK (1) HK1037141A1 (no)
HU (1) HUP0100171A3 (no)
NO (2) NO324694B1 (no)
RU (1) RU2292891C2 (no)
WO (1) WO1999029308A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533023B4 (de) * 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
US20050175667A1 (en) * 2004-02-10 2005-08-11 Wenda Carlyle Use of endothelin antagonists to prevent restenosis
JP2010536880A (ja) 2007-08-22 2010-12-02 ギリード・コロラド・インコーポレーテッド 糖尿病の合併症のための療法
TWI701253B (zh) * 2011-11-11 2020-08-11 美商基利阿波羅有限責任公司 Ａｃｃ抑制劑及彼等之用途
EA201700155A1 (ru) * 2014-10-20 2017-10-31 Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" Фармацевтическая композиция для лечения туберкулеза
AR106472A1 (es) 2015-10-26 2018-01-17 Gilead Apollo Llc Inhibidores de acc y usos de los mismos
KR20180082557A (ko) 2015-11-25 2018-07-18 길리어드 아폴로, 엘엘씨 트리아졸 acc 억제제 및 그의 용도
CA3004798C (en) 2015-11-25 2023-10-31 Gilead Apollo, Llc Ester acc inhibitors and uses thereof
KR20180086191A (ko) 2015-11-25 2018-07-30 길리어드 아폴로, 엘엘씨 2,4-디옥소-1,4-디히드로티에노[2,3-d]피리미딘 유도체를 함유하는 살진균 조성물
BR112018010113B1 (pt) 2015-11-25 2022-06-14 Gilead Apollo, Llc Composto de pirazol útil como inibidor da acetil-coa carboxilase (acc)
CA3220447A1 (en) 2016-03-02 2017-09-08 Gilead Apollo, Llc Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof
JP6906626B2 (ja) 2017-03-28 2021-07-21 ギリアード サイエンシーズ， インコーポレイテッド 肝疾患を処置するための治療的組み合わせ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0670320A4 (en) * 1992-12-01 1997-05-02 Green Cross Corp DERIVATIVE OF 1,8-NAPHTHYRIDIN-2-ONE AND USE OF THIS DERIVATIVE.
US5998468A (en) * 1995-08-24 1999-12-07 Warner-Lambert Company Furanone endothelin antagonists
JP3116347B2 (ja) * 1996-11-13 2000-12-11 田辺製薬株式会社 医薬組成物

Also Published As

Publication number Publication date
ATE204172T1 (de) 2001-09-15
RU2003138080A (ru) 2005-06-10
ES2162493T3 (es) 2001-12-16
WO1999029308A3 (de) 1999-09-30
AU2153599A (en) 1999-06-28
CZ300442B6 (cs) 2009-05-20
AU751053B2 (en) 2002-08-08
US6197780B1 (en) 2001-03-06
DE19754082A1 (de) 1999-06-10
NO324694B1 (no) 2007-12-03
HUP0100171A2 (hu) 2003-02-28
BR9815335A (pt) 2000-10-17
HK1037141A1 (en) 2002-02-01
KR20010032779A (ko) 2001-04-25
WO1999029308A2 (de) 1999-06-17
DE59801230D1 (de) 2001-09-20
CA2311423C (en) 2008-01-29
CN1152685C (zh) 2004-06-09
CN1301162A (zh) 2001-06-27
EP1035851B1 (de) 2001-08-16
RU2292891C2 (ru) 2007-02-10
JP2002512173A (ja) 2002-04-23
CA2311423A1 (en) 1999-06-17
EP1035851A2 (de) 2000-09-20
NO20002777L (no) 2000-06-02
NO20002777D0 (no) 2000-05-30
CZ20002006A3 (cs) 2000-11-15
HUP0100171A3 (en) 2003-10-28

Similar Documents

Publication Publication Date Title
NO20074419L (no) Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom
ATE524176T1 (de) Valsartan tablette
EE04630B1 (et) Tsentraalse kannabinoidretseptori antagonistide kasutamine ravimi valmistamisel apetentsi reguleerimiseks
MA22758A1 (fr) Antagonistes des recepteurs d'endotheline
IS5500A (is) Lyfjablöndur til öftrunar og meðferðar mýlildi ogtengdum sjúkdómum
EP0837927A4 (en) MONOCLONAL MONKEY ANTIBODIES AGAINST HUMANE B7.1 AND / OR B7.2 ANTIGEN, PRIMATIZED DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS
ATE75407T1 (de) Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker.
FR2663837B1 (fr) Prothese articulee du ligament croise anterieur du genou humain.
FI960953A (fi) Endoteliinireseptoriantagonisteja
FR2671856B1 (fr) Dome d'ensemble de combustion.
NO971206D0 (no) Forlenget-frigjöringsformulering
MD1745C2 (ro) 4,5-dimetil-N-2-propenil-2-(trimetilsilil)-3-tiofencarboxamidă, compoziţie fungicidă pe baza ei şi metodă de combatere a bolilor de plante
IT243536Y1 (it) Apparecchio ortodontico per l'espansione e la contrazione ortodonticae ortopedica del mascellare superiore.
DE69814394D1 (de) Verwendung von levobupivacain
DE3889062D1 (de) Monoklonaler Antikörper gegen humanen BCDF.
SE9700934D0 (sv) New formulation
IS2356B (is) Notkun á sértæku mótlyfi fyrir 5HT2 viðtaka til framleiðslu á læknislyfjum sem eru nytsamleg við meðhöndlun á svefn-truflaðri öndun
IS5366A (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
IS4597A (is) Ný lyfjafræðileg notkun AII-viðtaka mótlyfja
DE69618560T2 (de) Medikament gegen ophthalmische erkrankungen
ITTO950541A0 (it) Dispositivo per il controllo dell'odore.
FR2673375B1 (no)
FI942400A0 (fi) Lääkeaine hermosairauksia vastaan
DE69636597D1 (de) Endothelin rezeptor antagonisten
NO20001894D0 (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application